SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BARALDI, Pier Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 37.254
AS - Asia 16.257
EU - Europa 11.552
SA - Sud America 2.696
AF - Africa 309
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 30
Totale 68.133
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 36.664
SG - Singapore 5.948
CN - Cina 5.264
DE - Germania 3.369
UA - Ucraina 2.312
BR - Brasile 2.277
TR - Turchia 1.766
HK - Hong Kong 1.534
GB - Regno Unito 1.263
IT - Italia 1.069
RU - Federazione Russa 871
SE - Svezia 852
VN - Vietnam 779
FI - Finlandia 705
FR - Francia 321
MX - Messico 295
CA - Canada 249
PL - Polonia 230
IN - India 218
AR - Argentina 169
ZA - Sudafrica 154
JP - Giappone 132
NL - Olanda 116
BD - Bangladesh 100
BE - Belgio 98
ID - Indonesia 82
ES - Italia 75
IQ - Iraq 68
MA - Marocco 57
EC - Ecuador 52
CO - Colombia 48
CZ - Repubblica Ceca 45
LT - Lituania 45
KR - Corea 44
CL - Cile 43
PY - Paraguay 42
PK - Pakistan 38
AT - Austria 33
TW - Taiwan 30
EG - Egitto 29
UZ - Uzbekistan 29
IR - Iran 28
AE - Emirati Arabi Uniti 27
AU - Australia 26
SA - Arabia Saudita 26
IL - Israele 25
EU - Europa 24
VE - Venezuela 23
KE - Kenya 21
UY - Uruguay 19
JO - Giordania 16
NP - Nepal 16
PE - Perù 15
CH - Svizzera 14
TN - Tunisia 14
GR - Grecia 13
MY - Malesia 13
RO - Romania 13
IE - Irlanda 12
BG - Bulgaria 11
PT - Portogallo 11
DZ - Algeria 10
KZ - Kazakistan 10
AZ - Azerbaigian 9
HU - Ungheria 9
NO - Norvegia 9
NZ - Nuova Zelanda 9
LV - Lettonia 8
MD - Moldavia 8
TT - Trinidad e Tobago 8
AL - Albania 7
KG - Kirghizistan 7
OM - Oman 7
BH - Bahrain 6
BO - Bolivia 6
PA - Panama 6
PS - Palestinian Territory 6
TH - Thailandia 6
DO - Repubblica Dominicana 5
HN - Honduras 5
HR - Croazia 5
RS - Serbia 5
CI - Costa d'Avorio 4
LB - Libano 4
MK - Macedonia 4
NI - Nicaragua 4
PH - Filippine 4
SN - Senegal 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
AO - Angola 3
BY - Bielorussia 3
DK - Danimarca 3
ET - Etiopia 3
GA - Gabon 3
GT - Guatemala 3
MT - Malta 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
Totale 68.093
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.789
Fairfield 3.579
Singapore 3.440
Ashburn 3.113
Dallas 2.733
Houston 2.465
Jacksonville 2.448
Chandler 2.073
Ann Arbor 1.911
Seattle 1.521
Hong Kong 1.514
Santa Clara 1.470
Beijing 1.449
Wilmington 1.377
Cambridge 1.092
Izmir 800
Nanjing 774
Princeton 511
Los Angeles 432
Boardman 399
Munich 367
New York 341
San Diego 321
Ferrara 270
Shenyang 263
Ho Chi Minh City 237
Milan 226
Hefei 219
Shanghai 217
Nanchang 213
São Paulo 206
Mexico City 184
Warsaw 184
Tianjin 177
Hebei 157
Falkenstein 154
San Mateo 153
London 152
Changsha 148
Bremen 144
Hanoi 144
Addison 141
Chicago 124
Helsinki 122
Jiaxing 121
Dearborn 114
Dong Ket 114
Turku 112
Jinan 110
Tokyo 105
Brooklyn 101
Brussels 97
Philadelphia 92
Falls Church 86
Norwalk 84
Moscow 83
Frankfurt am Main 82
The Dalles 82
Kunming 79
Montreal 79
Redwood City 78
Zhengzhou 75
Rio de Janeiro 73
San Francisco 71
Amsterdam 67
Johannesburg 67
Toronto 60
Atlanta 59
Mountain View 59
Guangzhou 58
Buffalo 57
Chennai 56
Phoenix 55
Boston 53
Ningbo 51
Orem 51
Denver 50
Belo Horizonte 49
Brasília 49
Poplar 49
Stockholm 49
Auburn Hills 47
Orange 47
Verona 43
Des Moines 42
Jakarta 39
Manchester 38
Indiana 37
Hangzhou 36
Taizhou 36
Council Bluffs 33
Curitiba 33
Lanzhou 32
Haiphong 31
Ankara 30
Dhaka 29
Mumbai 29
Campinas 28
Columbus 28
Paris 28
Totale 45.197
Salva come PNG Salva come JPEG
Nome #
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 1.171
1,4-Diketones via Isoxazole Intermediates 1.164
1,2,3-triazolo[5,4-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: A new class of A(2A) adenosine receptor antagonists 1.125
[2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid inhibits DNA binding to transcription factor Sp1 481
A glance at adenosine receptors: Novel target for antitumor therapy 261
1-methyl-3-nitro-5-methoxycarbonyl pyrazole 256
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 252
A facile, efficient synthesis of 2-substituted-4-hydroxy-2-cyclopenten-1-ones 245
A new, efficient synthesis of muscimol (5-ammoniomethylisoxazol-3-olate). 241
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 236
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 235
3,5-Disubstituted isoxazoles as a latent aldol moiety: Application to the synthesis of (±)-[6]-gingerol 234
Azaprostaglandin Analogues. Synthesis and Biological Properties of 11-Azaprostaglandin Derivatives 232
A [3+2] nitrile oxide intermolecular cycloaddition approach to 4,5-dihydro-3(2H)-furanone and 3(2H)-furanone ring systems: application to the formal synthesis of (±)-ascofuranone and geiparvarin. 232
A synthetic approach for the preparation of rigid analogs of 1,3-dipropyl-7-methyl-8-aryl/heteroarylstyryl xanthines 230
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 230
A formal total synthesis (±)-forskolin through [3+2] nitrile oxide cycloaddition chemistry 229
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 229
A3 adenosine receptor antagonists: History and future perspectives 228
null 227
2,3a,5,6,7,7a-Hexahydro-3H,4H-benzothiophene-3,4-dione and cyclopenta[b]tetrahydrothiophene-3,4-dione enolate anions as synthetic equivalents to cyclohex-2-enone and cyclopent-2-enone C-2-carbanions. 222
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: A promising approach for treating pain and inflammation 222
A convenient synthesis of unsymmetrically substituted terphenyls of biologically active stilbenes via a double Suzuki cross-coupling protocol 221
Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3’,4’,5’-Trimethoxyphenyl)-2-Aryl-1H-Imidazole 218
Design, synthesis and biological evaluation of 3-substituted-2-oxindole hybrid derivatives as novel anticancer agents 218
The A3 adenosine receptor: history and perspectives 216
A [3 + 2] nitrile oxide cycloaddition approach to retinoids 215
Adenosine receptors and human melanoma 215
Allosteric modulators for the A1-adenosine receptor 214
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 212
Design, synthesis, DNA binding, and biological evaluation of water-soluble hybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders 212
Design, synthesis and in vitro cytotoxicity of a cis-dichloroplatinum(II) complex linked to the minor groove binder stallimycin 208
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 208
DNA minor groove binders as potential antitumor and antimicrobial agents 207
Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents 206
The use of phase-transfer catalysis for the N-alkylation of indole. 205
A new nitrile oxide based synthesis of the antitumor agent geiparvarin 204
Allosteric enhancers for A(1) adenosine receptor 204
Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor 204
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 204
3,5-Disubstituted Isoxazoles as Synthons for (±)-Pyrenophorin and (±)-Vermiculine Synthesis 203
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 203
Design, synthesis, in vitro, and in vivo anticancer and antiangiogenic activity of novel 3-arylaminobenzofuran derivatives targeting the colchicine site on tubulin 202
Active γ-manganese dioxide promoted conversion of 4,5-dihydro-1,2-oxazoles to 1,2-oxazoles. 202
Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility 201
1H-pyrazolo[2,3-d][1,2,4]triazine-3,7-diones as a new class of human leukocyte elastase inhibitors 200
Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH) 197
Synthesis and biological evaluation of 2-and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization 196
Blockade of A2A receptors plus L-DOPA after nigrostriatal lesion results in GAD67 mRNA changes different from L-DOPA alone in the rat globus pallidus and substantia nigra reticulata 196
2-Arylamino-4-amino-5-aroylthiazoles. "One-pot" synthesis and biological evaluation of a new class of inhibitors of tubulin polymerization 196
Novel 8-heterocyclyl xanthine derivatives in drug development - An update 196
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 195
History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agents 195
Binding of hybrid molecules containing pyrrolo [2,1-c][1,4]benzodiazepine (PBD) and oligopyrrole carriers to the human immunodeficiency type 1 virus TAR-RNA 193
Novel iodoacetamido benzoheterocyclic derivatives with potent antileukemic activity are inhibitors of STAT5 phosphorylation 193
A new direct glycosylation of pyrimidine, pyrazole, imidazole and purine heterocycles via their N-tetrahydropyranyl (THP) derivatives 193
Pyrazolo [4,3-e][1,2,4]triazolo[1,5-c]pyrimidine template: Organic and medicinal chemistry approach 192
Synthesis and preliminary biological evaluation of new anti-tubulin agents containing different benzoheterocycles 191
Ethyl 2,4-dioxoalkanoates as starting materials for a convenient route to 3(2H)-furanones and 3(2H)-furanimines 190
From tyrosine to glycine: Synthesis and biological activity of potent antagonists of the purinergic P2X(7) receptor 190
Hybrid molecules based on distamycin A as potential antitumor agents 190
A new simple synthesis of a-substituted acrylonitriles 188
Current status of A1 adenosine receptor allosteric enhancers 188
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 188
Hybrid molecules between distamycin A and active moieties of antitumor agents 188
Geiparvarin analogs. 2. Synthesis and cytostatic activity of 5-(4-arylbutadienyl)-3(2H)-furanones and of N-substituted 3-(4-oxo-2-furanyl)-2-buten-2-yl carbamates. 187
Discovery and Optimization of a Series of 2-Aryl-4-Amino-5-(3 ',4 ',5 '-trimethoxybenzoyl)Thiazoles as Novel Anticancer Agents 187
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2 186
Design, synthesis and antiproliferative activity of novel heterobivalent hybrids based on imidazo[2,1-b][1,3,4]thiadiazole and imidazo[2,1-b][1,3]thiazole scaffolds 186
Synthesis, in vitro antiproliferative activity, and DNA-binding properties of hybrid molecules containing pyrrolo[2,1-c][1,4] benzodiazepine and minor-groove-binding oligopyrrole carriers 186
A one-pot glycosylation of tetrahydropyranyl (THP) ether intermediates 185
Carboxyl activation in peptide synthesis using 4-oximino-pyrazol-5-ones 185
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: Induction of production of fetal hemoglobin in human erythroid precursor cells 185
Synthesis and biological evaluation of 2-(3 ',4 ',5 '-trimethoxybenzoyl)-3-amino 5-aryl thiophenes as a new class of tubulin inhibitors 184
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 184
Structure-activity relationship studies of a new series of imidazo[2,1-f] purinones as potent and selective A3 adenosine receptor antagonists 183
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 183
Synthesis of hybrid distamycin-cysteine labeled with 99mTc: a model for a novel class of cancer imaging agents 182
Methyl 4-oxothiolane-3-carboxylate and methyl 2-methyl-4-oxothiolane-3- carboxylate anions as synthetic equivalents of α-acrylate and α-crotonate anions. Formal synthesis of integerrinecic acid 181
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 181
A new synthetic approach to indazole synthesis 181
Geiparvarin Analogs. 4.1. Synthesis and Cytostatic Activity of Geiparvarin Analogs Bearing a Carbamate Moiety or a Furocoumarin Fragment on the Alkenyl Side Chain 180
Cinnamoyl nitrogen mustard derivatives of pyrazole analogues of tallimustine modified at the amidino moiety: design, synthesis, molecular modeling and antitumor activity studies 180
A mild one-pot synthesis of thieno[3,4-c]pyrazoles and their conversion into pyrazole analogs of o-quinodimethane 180
Transient receptor potential ankyrin receptor 1 is a novel target for pro-tussive agents 180
Design, synthesis and growth inhibition activity of bis-epoxyethyl derivatives of stallimycin modified on the amidino moiety 179
Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and linked Heterocycles as template for the adenosine receptor antagonism: Medicinal chemistry approach and sar considerations 179
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 179
A new synthetic approach to pyrazolo[3,4-c]-1,2,5-oxadiazoles 178
[3H]-MRE 2029-F20, a novel selective antagonist radioligand, for the pharmacological and biochemical characterization of A2B receptors. 178
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 177
Synthesis of a new series of pyrazolo[1,5-a]pyrimidines structurally related to zaleplon 176
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 176
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 176
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene 176
Geiparvarin Analogs. 3. Synthesis and cytostatic activity of 3(2H)-furanone and 4,5-dihydro-3(2H)-furanone congeners of geiparvarin, containing a geraniol-like fragment in the side chain 175
Preparation of 3,4-dihydroxy-1-benzeneethanol: a reinvestigation 174
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N- (substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor 174
Synthesis of conformationally constrained analogues of KN62, a potent antagonist of the P2X7-receptor 173
5-heteroarylcarbamoylamino-pyrazolo-triazolo pyrimidines as hA3 adenosine receptor antagonists. 173
Totale 23.148
Salva come PNG Salva come JPEG
Categoria #
all - tutte 296.027
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.972
Totale 298.999
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.814 0 0 0 0 0 648 146 726 122 784 835 553
2021/20225.094 159 470 372 291 373 250 208 243 197 361 528 1.642
2022/20234.800 508 249 108 646 881 773 145 390 611 31 286 172
2023/20242.411 243 307 129 82 170 287 95 394 28 60 56 560
2024/20259.331 291 294 752 335 1.154 770 273 638 1.285 1.084 1.377 1.078
2025/202615.996 2.653 1.709 4.045 3.576 3.659 354 0 0 0 0 0 0
Totale 68.612